| 000 | 00983 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518005406.0 | ||
| 264 | 0 | _c20190118 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1080/14656566.2018.1540592 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRasche, Ludwig | |
| 245 | 0 | 0 |
_aOzanimod for the treatment of relapsing remitting multiple sclerosis. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cDec 2018 |
||
| 300 |
_a2073-2086 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xpharmacology |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 700 | 1 | _aPaul, Friedemann | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 19 _gno. 18 _gp. 2073-2086 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14656566.2018.1540592 _zAvailable from publisher's website |
| 999 |
_c29023725 _d29023725 |
||